Replies to post #20319 on Mymetics Corp (MYMX)

[Work Harder]

CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

http://www.healthtech.com/

Rinaldo Zurbriggen, Ph.D., Co-founder, Pevion Biotech, and Senior Program Manager, Lonza, Ltd.
Rinaldo Zurbriggen was co-founder and Chief Scientific Officer of Pevion Biotech. Prior to joining Pevion Biotech, Rinaldo Zurbriggen was head of the virus research department at Berna Biotech, where he was responsible for the development of virosome-based vaccines from 1996 on. During this period his department enabled Berna Biotech to register the first virosome-based vaccine (Epaxal) in Europe. Rinaldo Zurbriggen is a leading expert for virosomes and has published more than 50 papers in peer-reviewed scientific journals in this field. Rinaldo Zurbriggen earned his degree at the University of Fribourg, Switzerland. Currently, he is Senior Program Manager at Lonza.

http://www.healthtech.com/Conferences_Overview.aspx?id=98728

& you know where the Merck fella is

That's Boston baby

Mario has been to Boston I believe

https://www.virometix.com/about-us/our-company/#Advisory-Board

It's going to get real

:}